• Biodyne issued a correction to its June 2026 semiannual report to add missing treasury-share disclosures.
• Treasury shares totaled 287,343 common shares as of June 30, 2026, equal to 0.97% of issued shares.
• The shares were acquired at no cost from the CEO in 2021, with an indicated cancellation deadline in 2027.
• Planned use remains share dividends or employee share compensation, with disposal approval targeted for the 2027 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodyne Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261012000030), on October 12, 2026, and is solely responsible for the information contained therein.